Key Points
- CEO Parth Mehrotra sold a total of 84,536 shares across March 6, 9 and 10 for about $1.94 million, cutting his ownership by 6.14% to 322,698 shares now valued at roughly $7.33 million.
- Privia posted a strong quarter (EPS $0.25 vs $0.04 estimate, revenue $541.2M, up 17.4% YoY) and analysts remain mostly positive—13 Buys and 3 Holds—with a consensus Moderate Buy and an average price target of $31.00.
Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) CEO Parth Mehrotra sold 21,097 shares of the firm's stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $22.71, for a total value of $479,112.87. Following the completion of the sale, the chief executive officer directly owned 322,698 shares of the company's stock, valued at $7,328,471.58. The trade was a 6.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Parth Mehrotra also recently made the following trade(s):
- On Monday, March 9th, Parth Mehrotra sold 41,999 shares of Privia Health Group stock. The stock was sold at an average price of $22.86, for a total transaction of $960,097.14.
- On Friday, March 6th, Parth Mehrotra sold 21,440 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total transaction of $496,336.00.
Privia Health Group Stock Down 1.0%
NASDAQ:PRVA traded down $0.23 during mid-day trading on Friday, hitting $21.50. 230,616 shares of the stock traded hands, compared to its average volume of 803,692. Privia Health Group, Inc. has a 52 week low of $18.77 and a 52 week high of $26.51. The stock has a market capitalization of $2.66 billion, a price-to-earnings ratio of 126.41, a PEG ratio of 1.39 and a beta of 0.82. The firm's 50 day moving average is $22.93 and its two-hundred day moving average is $23.58.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Thursday, February 26th. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.21. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The business had revenue of $541.17 million during the quarter, compared to the consensus estimate of $516.61 million. During the same quarter last year, the firm earned $0.21 earnings per share. The firm's quarterly revenue was up 17.4% compared to the same quarter last year. As a group, research analysts predict that Privia Health Group, Inc. will post 0.14 EPS for the current year.
Analyst Ratings Changes
Several research analysts recently commented on the stock. Citigroup reduced their price target on shares of Privia Health Group from $34.00 to $32.00 and set a "buy" rating on the stock in a research note on Tuesday, March 3rd. Weiss Ratings reissued a "hold (c)" rating on shares of Privia Health Group in a research report on Monday, December 29th. Truist Financial raised their target price on shares of Privia Health Group from $31.00 to $33.00 and gave the stock a "buy" rating in a research report on Monday, March 2nd. Jefferies Financial Group reaffirmed a "buy" rating and set a $32.00 price target on shares of Privia Health Group in a research note on Thursday, February 26th. Finally, Canaccord Genuity Group boosted their price target on Privia Health Group from $34.00 to $35.00 and gave the company a "buy" rating in a report on Friday, February 27th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $31.00.
Check Out Our Latest Research Report on PRVA
Hedge Funds Weigh In On Privia Health Group
Institutional investors have recently bought and sold shares of the business. Bayban purchased a new stake in Privia Health Group during the fourth quarter worth $26,000. Hantz Financial Services Inc. increased its holdings in shares of Privia Health Group by 456.2% in the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company's stock valued at $27,000 after acquiring an additional 926 shares during the period. Global Retirement Partners LLC increased its holdings in shares of Privia Health Group by 579.8% in the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company's stock valued at $38,000 after acquiring an additional 1,351 shares during the period. Canada Pension Plan Investment Board raised its position in shares of Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company's stock worth $85,000 after acquiring an additional 1,200 shares in the last quarter. Finally, Kestra Advisory Services LLC purchased a new stake in shares of Privia Health Group during the 4th quarter worth $93,000. 94.48% of the stock is owned by hedge funds and other institutional investors.
About Privia Health Group
(
Get Free Report)
Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.
Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
